Drugs / GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00980850 | Sep → Dec 2009 | influenza | University of Oxford | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00980850 ↗ |
| Modality | Vaccine | “GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine” NCT00980850 ↗ |